Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 14, 2022 08:00 ET | Source: iCAD, Inc.

iCAD Highlights Breast Health AI Platform at the 2022 Healthcare Information and Management Systems Society (HIMSS) Meeting

NASHUA, N.H., March 14, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will be...
March 10, 2022 08:00 ET | Source: iCAD, Inc.

iCAD Showcases Innovative Breast Health Solutions Platform at National Consortium of Breast Centers (NCoBC) 31st Annual Conference

NASHUA, N.H., March 10, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will be...
March 09, 2022 11:21 ET | Source: iCAD, Inc.

iCAD to Present at the 32nd Annual Oppenheimer Healthcare Conference

NASHUA, N.H., March 09, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the...
March 02, 2022 08:00 ET | Source: iCAD, Inc.

iCAD Among the First to Validate its AI Cancer Detection Solutions with the NVIDIA AI Enterprise Software Suite

NASHUA, N.H., March 02, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it is...
March 01, 2022 08:00 ET | Source: iCAD, Inc.

iCAD to Present at the 42nd Annual Cowen Health Care Conference

NASHUA, N.H., March 01, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the...
February 28, 2022 16:05 ET | Source: iCAD, Inc.

iCAD Reports Financial Results for Fourth Quarter and Year Ended December 31, 2021

Launched ProFound AI® Risk, the world’s first clinical decision support tool for short term breast cancer risk estimation Demonstrated compelling survival data for the use of Xoft® Brain IORT in...
February 14, 2022 16:05 ET | Source: iCAD, Inc.

iCAD to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28

NASHUA, N.H., Feb. 14, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
February 08, 2022 08:00 ET | Source: iCAD, Inc.

iCAD to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

NASHUA, N.H., Feb. 08, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company...
January 24, 2022 14:25 ET | Source: iCAD, Inc.

iCAD’s Breast AI Platform Earns U.S. Department of Defense Authorization to Operate

NASHUA, N.H., Jan. 24, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the...
January 11, 2022 08:00 ET | Source: iCAD, Inc.

iCAD Announces the Appointment of New Members to its Board of Directors

NASHUA, N.H., Jan. 11, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, announced today it has...